TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Redo Biosolutions AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
99,435
|
87,811
|
44,956 |
| Financial expenses |
1
|
5
|
3 |
| Earnings before taxes |
17,435
|
17,414
|
-817 |
| EBITDA |
20,191
|
19,439
|
532 |
| Total assets |
73,149
|
55,689
|
29,855 |
| Current assets |
53,268
|
33,319
|
19,471 |
| Current liabilities |
26,234
|
23,615
|
11,392 |
| Equity capital |
45,955
|
32,075
|
18,463 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
4
|
3
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
62.8%
|
57.6%
|
61.8% |
| Turnover per employee |
24,859
|
29,270 | |
| Profit as a percentage of turnover |
17.5%
|
19.8%
|
-1.8% |
| Return on assets (ROA) |
23.8%
|
31.3%
|
-2.7% |
| Current ratio |
203.0%
|
141.1%
|
170.9% |
| Return on equity (ROE) |
37.9%
|
54.3%
|
-4.4% |
| Change turnover |
11,171
|
46,497
|
6,497 |
| Change turnover % |
13%
|
113%
|
17% |
| Chg. No. of employees |
1
|
3
|
0 |
| Chg. No. of employees % | 33% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.